sodium sulfide
Sodium sulfide is a chemical compound with the formula Na2S, or more commonly its hydrate Na2S·9H2O. Both the anhydrous and the hydrated salts are colorless solids, although technical grades of sodium sulfide are generally yellow to brick red owing to the presence of polysulfides. It is commonly supplied as a crystalline mass, in flake form, or as a fused solid. They are water-soluble, giving strongly alkaline solutions. When exposed to moisture, Na2S immediately hydrates to give sodium hydrosulfide. Sodium sulfide has an unpleasant rotten egg smell due to the hydrolysis to hydrogen sulfide in moist air. — Wikipedia
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Earliest trial started May 1, 2009 (NCT00858936)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
SMILES
O.O.O.O.O.O.O.O.O.[Na+].[Na+].[S-2]- Mol. weight
- 240.18 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3989793 ↗
- WikipediaSodium sulfide ↗
- NCATSG15I91XETI ↗
- ChEMBLCHEMBL2107611 ↗
Also known as
- actisoufre
- na2s
- sodium sulfide
- sodium sulfide
- sodium sulfide
- sodium sulfide
- sodium sulfide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01007461 | Phase 2 | Dec 1, 2009 | Mallinckrodt |
| NCT00879645 | Phase 1 | Aug 1, 2009 | Mallinckrodt |
| NCT00858936 | Phase 2 | May 1, 2009 | Mallinckrodt |
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mallinckrodt | For profit | 3 | 3 | 2 | 2009 |